Patents-Review.com
ClassID:

96735 ⎘

C07K7/04 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof Linear peptides containing only normal peptide links

Sub-classes:
Recent Application in this class:
#1
20260109734
2026-04-23

PEPTIDE WITH NEUTRALIZING ACTIVITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2

 #2
20260034193
2026-02-05

Brevican-Binding Peptides for Brain Tumor Imaging

 #3
20240392319
2024-11-28

TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME

 #4
20240317803
2024-09-26

BCL9 PEPTIDES AND VARIANTS THEREOF

 #5
20240228671
2024-07-11

POLYPEPTIDYL LINKERS

 #6
20240226306
2024-07-11

TREM-2/DAP-12 INHIBITORS FOR TREATING LUNG DISEASE AND INJURY AND COMBINATIONS THEREOF

 #7
20240051993
2024-02-15

PEPTIDE WITH NEUTRALIZING ACTIVITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2

 #8
20230399374
2023-12-14

Compounds, Compositions and Methods of Use to Treat Bone Fractures

 #9
20230313126
2023-10-05

Peptide Conjugated Hydrogel Substrate for the Maintenance and Expansion of Human Pluripotent Stem Cells

 #10
20230295227
2023-09-21

COMPOUNDS FOR USE IN DIAGNOSIS AND/OR MONITORING OF FIBROSIS

 #11
20230242604
2023-08-03

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #12
20230203749
2023-06-29

ANTIVIRAL FABRIC

 #13
20230201405
2023-06-29

ANTIVIRAL FILTER MEDIUM, AND AIR FILTER UNIT AND AIR CONDITIONER INCLUDING SAME

 #14
20230026155
2023-01-26

Peptoid compound and detection chip coupled with peptoid compound on the surface

 #15
20230023408
2023-01-26

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #16
20230012265
2023-01-12

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #17
20230002464
2023-01-05

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #18
20230002463
2023-01-05

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #19
20220370624
2022-11-24

LIPID COMPOSITIONS COMPRISING PEPTIDE-LIPID CONJUGATES

 #20
20220315909
2022-10-06

PROTEASE SUBSTRATE, AND POLYPEPTIDE INCLUDING PROTEASE CLEAVAGE SEQUENCE

 #21
20220313770
2022-10-06

IMMUNOTHERAPY FOR ANGIOGENIC DISEASE

 #22
20220153865
2022-05-19

SYNTHETIC PEPTIDE, RELATIVE ARTIFICIAL ANTIGEN, RELATIVE ANTI-EHD2 ANTIBODY AND PREPARATION METHOD THEREOF AND USE THEREOF

 #23
20220090141
2022-03-24

Transfection complexes and methods of using the same

 #24
20210353708
2021-11-18

Brevican-Binding Peptides for Brain Tumor Imaging

 #25
20210324044
2021-10-21

Heterologous targeting peptide grafted AAVs

 #26
20210277080
2021-09-09

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #27
20210230240
2021-07-29

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #28
20210060116
2021-03-04

Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

 #29
20200399334
2020-12-24

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #30
20200339646
2020-10-29

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #31
20200339645
2020-10-29

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #32
20200262867
2020-08-20

BCL9 peptides and variants thereof

 #33
20200216492
2020-07-09

USE OF C-TERMINALLY EXTENDED PEPTIDES TO DISRUPT INHIBITOR NK CELL RECEPTOR INTERACTIONS WITH MHC I

 #34
20200207834
2020-07-02

Gene transfer systems for stem cell engineering

 #35
20200157165
2020-05-21

PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF

 #36
20200087363
2020-03-19

B*44 restricted peptides for use in immunotherapy against cancers and related methods

 #37
20200078436
2020-03-12

Immunotherapy for angiogenic disease

 #38
20200023029
2020-01-23

Immunotherapy for angiogenic disease

 #39
20190389934
2019-12-26

Heterologous targeting peptide grafted AAVS

 #40
20190241673
2019-08-08

Synthetic peptide, relative artificial antigen, relative anti-EHD2 antibody and preparation method thereof and use thereof

 #41
20190080044
2019-03-14

Monitoring and diagnosis for immunotherapy, and design for therapeutic agent

 #42
20190071467
2019-03-07

Pharmacologically active peptide compound, process for the preparation and use thereof

 #43
20190023739
2019-01-24

Peptide for cancer treatment and pharmaceutical composition containing same

 #44
20190022179
2019-01-24

Isolated polypeptide and compositions comprising same

 #45
20180348234
2018-12-06

Peptide combinations for use in the diagnosis of schizophrenia

 #46
20180340188
2018-11-29

Transfection complexes and methods of using the same

 #47
20180282371
2018-10-04

Protein based adhesive composition and method

 #48
20180265571
2018-09-20

Heterologous targeting peptide grafted AAVS

 #49
20180171286
2018-06-21

Peptide conjugated hydrogel substrate for the maintenance and expansion of human pluripotent stem cells

 #50
20170368131
2017-12-28

Immunotherapy for angiogenic disease

 #51
20170333539
2017-11-23

Anti-IL-6 vaccine composition

 #52
20170258930
2017-09-14

SKIN PENETRATING PEPTIDES (SPPS) AND METHODS OF USE THEREFOR

 #53
20170252718
2017-09-07

Heat insulation material based on aerogel

 #54
20160362466
2016-12-15

Peptides having osteoblast growth-promoting activity and use thereof

 #55
20160250325
2016-09-01

Adjuvant compound

 #56
20160145301
2016-05-26

Process for the manufacture of degarelix and its intermediates

 #57
20160032017
2016-02-04

Antibodies specific to a novel epitope on CεMX of human membrane-bound IgE and uses thereof in treating IgE-mediated diseases

 #58
20160030515
2016-02-04

Use of antisecretory factors (AF) for optimizing cellular uptake

 #59
20150104473
2015-04-16

Adjuvant compound

 #60
20140322161
2014-10-30

Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6

 #61
20140259231
2014-09-11

Multi-Gene Expression Vehicle

 #62
20140221609
2014-08-07

Activation of sodium potassium ATPase

 #63
20130281662
2013-10-24

Process for the manufacture of Degarelix and its intermediates

 #64
20130281661
2013-10-24

Process for the manufacture of Degarelix and its intermediates

 #65
20130267457
2013-10-10

PEPTIDE INHIBITORS OF PROTEIN SYNTHESIS

 #66
20120226019
2012-09-06

Compounds and methods for purifying peptides produced by solid phase peptide synthesis

 #67
20120020956
2012-01-26

Antibodies that bind alpha subunit of sodium potassium ATPase

 #68
20110300199
2011-12-08

Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp

 #69
20110245175
2011-10-06

Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices

 #70
20110143998
2011-06-16

Identification and use of peptide inhibitors of protein synthesis

 #71
20100297096
2010-11-25

Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis

 #72
20070277263
2007-11-29

MULTI-GENE EXPRESSION VEHICLE

 #73
20050261473
2005-11-24

Carboxy protection strategies for acidic C-terminal amino acids in chemical ligation of oligopeptides

 #74
20050137137
2005-06-23

Inhibitors of the Interaction between p53 and MDM2